Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic

CMAJ. 2020 Aug 24;192(34):E982-E985. doi: 10.1503/cmaj.201237. Epub 2020 Jul 9.

Authors

Bahaa Abu-Raya¹, Soren Gantt², Manish Sadarangani²

Affiliations

¹ Vaccine Evaluation Center, BC Children's Hospital Research Institute, and Division of Infectious Diseases, Department of Pediatrics, University of British Columbia, Vancouver, BC baburaya@bcchr.ubc.ca.
² Vaccine Evaluation Center, BC Children's Hospital Research Institute, and Division of Infectious Diseases, Department of Pediatrics, University of British Columbia, Vancouver, BC.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Betacoronavirus*
COVID-19
COVID-19 Vaccines
Communicable Disease Control / organization & administration*
Coronavirus Infections / epidemiology*
Coronavirus Infections / prevention & control*
Drug Development / organization & administration*
Humans
Pandemics / prevention & control*
Pneumonia, Viral / epidemiology*
Pneumonia, Viral / prevention & control*
SARS-CoV-2
Viral Vaccines*

Substances

COVID-19 Vaccines
Viral Vaccines